HRTS vs JDOC

Tema ETF Trust Tema Heart & Health ETF against JPMorgan Healthcare Leaders ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
50%
23 shared positions
Fee gap
10 bp
JDOC is cheaper
1-year return gap
0.6 pts
JDOC is ahead
Larger fund
HRTS
$54M

Side by side

HRTSJDOC
FundTema ETF Trust Tema Heart & Health ETFJPMorgan Healthcare Leaders ETF
IssuerTemaJPMorgan
CategoryHealth CareHealth Care
Expense ratio0.75%0.65%
Assets$54M$9.1M
Average daily dollar volume$83K$14K
ListedNov 20, 2023Nov 1, 2023
FrenzyCap score1917
1-month return+0.1%−0.4%
3-month return−0.5%−0.1%
Year to date+2.6%+4.7%
1-year return+11.2%+11.7%
30-day volatility14.2%13.3%
Worst drawdown, 1 year−11.0%−9.7%
Trailing 12-month yield1.31%0.85%
Holdings4566
Top 10 weight49.1%46.6%
Look-through P/E143.371.2
Holdings vs fair value+2.1%+11.1%
Holdings above 200-day average72%71%
Net flow, latest 3 reported months−$698K thru May 2026−$2.8M thru Jul 2026
30-day implied volatility16.5%—
Holdings as ofas of May 31, 2026SEC filingas of Apr 30, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

67% of HRTS · 63% of JDOC
HoldingHRTSJDOC
LLY11.52%6.81%
UNH5.24%5.83%
MRK4.27%4.21%
AstraZeneca PLC4.00%4.57%
JNJ3.59%6.20%
TMO3.97%3.19%
Novo Nordisk A/S5.24%2.65%
ABBV2.40%6.58%
BMY2.09%3.50%
VRTX2.93%1.96%
DHR2.66%1.91%
EW1.75%1.83%
MCK1.71%1.78%
REGN1.67%2.19%
BSX1.42%2.04%
ISRG1.30%2.96%
Novartis AG3.38%1.04%
IONS0.82%0.84%
Ascendis Pharma A/S0.76%0.71%
DXCM1.92%0.64%
Medtronic PLC1.88%0.59%
ALNY1.14%0.31%
XENE0.89%0.27%

Sector mix of the stock holdings

SectorHRTSJDOCGap
Health Care70.5%66.0%+4.5%
Technology6.6%5.1%+1.5%
Consumer Staples0.0%2.7%−2.7%

More: full overlap table · HRTS holdings · JDOC holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.